Skip to Main Content

Paper Details

Genetically adjusted PSA levels for prostate cancer screening.
Nat Med
10
2023
PSA, Prostate-specific antigen, men, patients, prostate cancer, tumors
Author NameAffiliation
Sonja I BerndtNational Cancer Institute
John P ShelleyVanderbilt University Medical Center
Mitchell J MachielaNational Cancer Institute
Mitchell J MachielaNational Cancer Institute
Ian M ThompsonCHRISTUS Santa Rosa Medical Center Hospital
Stephen K Van Den EedenKaiser Permanente Northern California
Stephen J ChanockNational Cancer Institute
Stephen J ChanockNational Cancer Institute
Christopher A HaimanCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California
Christopher A HaimanNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
Christopher A HaimanCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California
Christopher A HaimanNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
David V ContiCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California
David V ContiNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
Robert J KleinIcahn School of Medicine at Mount Sinai
Jonathan D MosleyVanderbilt University Medical Center
Jonathan D MosleyVanderbilt University Medical Center
John S WitteUniversity of California san francisco
John S WitteStanford University School of Medicine
John S WitteStanford Cancer Institute, Stanford University School of Medicine
John S WitteStanford University
  • 1 - 21

Datasets